Skip to content
Responsive image
Vendor
Mohrbooks Literary Agency
Sebastian Ritscher
Original language
English

THE END OF ALZHEIMER'S

Dale E. Bredesen

The First Program to Prevent and Reverse Cognitive Decline

A groundbreaking plan based on scientific research and clinical results shown to prevent and reverse AD and cognitive decline by addressing metabolic imbalances with lifestyle modifications.
Everyone knows someone who has survived cancer, but until now, no one knows anyone who has survived Alzheimer’s.

In this paradigm shifting book, Dale Bredesen offers real hope to anyone looking to prevent and even reverse Alzheimer’s and cognitive decline. Revealing that Alzheimer’s is not one condition, as it is currently treated, but actually three,THE END OF ALZHEIMER’S outlines 36 metabolic factors (micronutrients, hormone levels, sleep, etc.) that can trigger “downsizing” in the brain. The protocol shows us how to rebalance these factors using lifestyle modifications like taking vitamin B12, eliminating gluten, or even improving oral hygiene.

The results are impressive. Of the first ten patients on the protocol, nine displayed significant improvement within three to six months; since then the protocol has yielded similar results with hundreds more patients. Now,THE END OF ALZHEIMER’S brings new hope to a broad audience of patients, caregivers, physicians, and treatment centers with a fascinating look inside the science and a complete step-by-step plan that fundamentally changes how we treat and even think about Alzheimer’s.

Dale Bredesen, MD,is internationally recognized as an expert in the mechanisms of neurodegenerative diseases such as Alzheimer’s disease. He graduated from Caltech, then earned his MD from Duke University Medical Center. He served as chief resident in neurology at the University of California, San Francisco (UCSF), before joining Nobel Laureate Stanley Prusiner’s laboratory at UCSF as a National Institutes of Health postdoctoral fellow. He held faculty positions at UCSF, UCLA, and the University of California, San Diego. Bredesen directed the Program on Aging at the Burnham Institute before coming to the Buck Institute in 1998 as its founding president and CEO. He is the chief medical officer of MPI Cognition.
Available products
Book

Published 2017-08-22 by Avery

Book

Published 2017-08-22 by Avery

Comments

UK/Commonw.: Vermillon/Ebury ; Spanish: Grijalbo Vital/PRH